Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? BellRing Brands (BRBR) , which belongs to the Zacks Medical - Products industry, could be a great candidate to consider.When looking at the last two reports, this nutritional supplements company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 27.54%, on average, in the last two quarters.For the most re ...

BellRing Brands (BRBR) ended the recent trading session at $67.52, demonstrating a +1.24% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.28%. Meanwhile, the Dow experienced a drop of 0.61%, and the technology-dominated Nasdaq saw a decrease of 0.33%.The nutritional supplements company's stock has climbed by 7.36% in the past month, exceeding the Medical sector's loss of 3.47% and the S&P 500's gain of 0.41%.The upcoming earnings release of Be ...

ST. LOUIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) today announced it will hold a conference call on Tuesday, November 19, 2024 at 9:00 a.m. EST to discuss financial results for the fourth quarter and fiscal year 2024 and fiscal year 2025 outlook and to respond to questions. Darcy H. Davenport, President and Chief Executive Officer, and Paul A. Rode, Chief Financial Officer, will participate in the call. BellRing also announced it plans to release its financial results for the fo ...

Company Performance - BellRing Brands (BRBR) closed at $65.10, reflecting a +0.96% increase from the previous day, outperforming the S&P 500's daily gain of 0.27% [1] - Over the past month, shares of BellRing Brands have appreciated by 5.51%, contrasting with the Medical sector's decline of 4.14% and the S&P 500's gain of 2% [1] Upcoming Earnings - The company is expected to report an EPS of $0.49, representing a 19.51% increase from the prior-year quarter [2] - The consensus estimate for quarterly revenue is $539.72 million, which is up 14.2% from the same period last year [2] Analyst Estimates - Recent changes to analyst estimates for BellRing Brands indicate evolving short-term business trends, with positive revisions reflecting analysts' confidence in the company's performance [3] - The Zacks Rank system, which incorporates these estimate changes, currently ranks BellRing Brands as 1 (Strong Buy) [5] Valuation Metrics - BellRing Brands has a Forward P/E ratio of 31.06, which is a premium compared to the industry's average Forward P/E of 22.15 [6] - The company has a PEG ratio of 1.51, while the Medical - Products industry average PEG ratio is 1.88 [7] Industry Context - The Medical - Products industry, part of the Medical sector, holds a Zacks Industry Rank of 67, placing it in the top 27% of over 250 industries [8]

BellRing Brands (BRBR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is BellRing Brands (BRBR) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. BellRing Brands is a member of our Medical group, which includes 1025 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 di ...

Group 1 - The core viewpoint is a buy rating for BellRing Brands (NYSE: BRBR) due to expected growth sustaining in the mid-teens range driven by supply ramp-up, demand momentum, and secular tailwinds [1] - The company is anticipated to benefit from a continuous increase in supply and demand, which supports its growth trajectory [1] - The investment approach combines fundamental, technical, and momentum investing strategies to enhance the investment process [1] Group 2 - The article serves as a platform for tracking investment ideas and connecting with like-minded investors [1] - There is no current stock or derivative position held in any mentioned companies, indicating a neutral stance on potential conflicts of interest [2] - The article reflects the author's personal opinions and does not represent any formal investment advice [3]

The food industry is ripe for consolidation now that the Federal Reserve is expected to cut interest rates in September. According to Kevin Dreyer, co-CIO of Value at Gabelli Funds, lower rates generally stimulate M&A activity. "One thing to note is that, as rates come down, that tends to lead to an upswing in M&A activity," Dreyer told CNBC on Friday, Aug. 23. "Food stocks have had a tough year — the consumer stretch, inflation has been biting them — they've been struggling with volume growth, but snacking ...

Financial Data and Key Metrics - Net sales for Q3 2024 were $515 million, up 16% YoY, with adjusted EBITDA at $120 million, a 38% increase YoY [14] - Adjusted EBITDA margins were 23.2%, exceeding expectations due to favorable gross margins [14] - Gross profit grew 40% to $190 million, with gross margins increasing by 630 basis points to 36.8% [16] - Cash flow from operations was $69 million in Q3 and $160 million year-to-date [17] - Net debt stood at $776 million, with net leverage at 1.8x, expected to remain below 2x in fiscal 2024 [17] Business Line Performance - Premier Protein net sales grew 20%, driven by strong volume growth in RTD shakes (19%) and powders [14] - Dymatize net sales decreased 3% domestically but saw 18% growth internationally [15] - Premier Protein RTD shake consumption grew 10% in Q3, accelerating to 20% in July, with household penetration reaching an all-time high of 19% [5][9] - Premier Protein Powder grew 44% in Q3, driven by distribution gains and strong velocities [10] Market Performance - The convenient nutrition category grew 7% in Q3, with RTD leading at 11% growth [8] - Premier Protein maintained a 21% market share in the RTD segment and is the number one brand in the broader convenient nutrition category [9] - Dymatize's international business grew 18% in Q3, representing 30% of the brand's total sales [12] Strategic Direction and Industry Competition - The company raised its fiscal 2024 guidance, expecting net sales growth of 18%-20% and adjusted EBITDA growth of 27%-30% [7][18] - Premier Protein is focusing on driving demand with increased marketing and promotional spend, particularly in Q4 [12][18] - The company is evaluating long-term strategies, including potential expansion into mainstream beverage aisles [27][29] - Innovation is a key focus, with plans for new product launches in 2025, particularly in the powder category [32] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in demand and increased production capacity, setting the stage for strong fiscal 2025 performance [6][7] - The company highlighted the strong tailwinds for the protein category, with broad consumer relevance across age groups and health goals [8] - Management noted the importance of maintaining safety stock levels to reduce volatility in consumption patterns [60] Other Important Information - The company repurchased 1.3 million shares at an average price of $58.08 per share, totaling $74 million, with $216 million remaining in the share repurchase authorization [17] - Incremental production capacity secured in Q4 will help fill customer inventory gaps and rebuild internal inventories to target safety stock levels [6][22] Q&A Session Summary Question: Impact of price increases on Premier RTD shakes [19] - The company confirmed plans to proceed with price increases, noting that favorability in input costs was primarily related to whey protein powders, not shakes [20] Question: Incremental capacity and future supply needs [21] - The incremental capacity secured was beyond original plans, with new capacity expected to be needed by 2026 [22] Question: Tailwinds and headwinds for fiscal 2025 [24] - Management expects increased marketing and promotional spend in 2025, along with inflationary pressures, particularly in the powder business [25] Question: Competitor shelf space expansion and Premier's strategy [26] - The company is actively pursuing strategies to increase visibility, including end-aisle displays and multiple store placements, while evaluating long-term moves into mainstream aisles [27][29] Question: Innovation plans for Premier Protein [31] - Innovation will focus on both "little eye" (pack size, format, flavor) and "big eye" (new product lines) innovations, with new launches expected in 2025 [32] Question: Dymatize marketing campaign [33] - The campaign focuses on brand awareness, leveraging NFL player Christian McCaffrey to highlight the premium nature of the product [34][35] Question: Customer response to pricing [38] - Pricing has been well-received, with no major pushback, as competitors have also taken price increases [39] Question: Private label competition [40] - Private label penetration is lower in the RTD and powder categories compared to other CPG categories, with branded players maintaining share [41] Question: Club channel performance and consumption trends [44] - Temporary changes in assortment and out-of-stocks impacted club channel performance, but consumption rebounded in July [46][47] Question: Target consumer base and household penetration [48] - The company is targeting younger consumers to drive household penetration growth, with marketing campaigns tailored to this demographic [50] Question: Volatility in consumption data [59] - Volatility is largely due to low safety stock and trade inventory levels, which will stabilize as inventory levels improve [60] Question: Long-term EBITDA margin outlook [62] - Management expects margins to remain strong but does not view the current high margins as the new normal, with further evaluation planned for fiscal 2025 [62] Question: Promotional intensity in the club channel [65] - Promotional activity has increased, particularly among smaller competitors, but the company remains confident in its pricing power [66][67] Question: Fall shelf resets and capacity for 2025 [71] - The company expects TDP growth in Q4, driven by new distribution and filling inventory gaps, with incremental capacity supporting 2025 growth [72] Question: Impact of shipment timing on consumption [74] - Delayed shipments in Q3 impacted consumption growth, with a 400 basis point headwind, but this rebounded in July [75][76] Question: Pricing power and competitive dynamics [77] - The company believes it has strong pricing power, as consumers are trading more expensive breakfast items for Premier Protein shakes [78] Question: Long-term innovation in active nutrition [80] - The company sees significant potential for protein-based innovation, particularly in combining protein with other functional ingredients [81] Question: Bottle capacity and competition [83] - Bottle capacity is also constrained, but the company sees growth potential in this format, particularly for expanding distribution [84]

Table of Contents Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________ FORM 10-Q __________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe ...